Most Popular Choices
Share on Facebook 72 Printer Friendly Page More Sharing Summarizing
OpEdNews Op Eds    H3'ed 8/15/24  

AIDS response caught in a debt trap

By       (Page 5 of 7 pages) Become a premium member to see this article and all articles as one long page.   No comments

Citizen News Service - CNS
Follow Me on Twitter     Message Citizen News Service - CNS
Become a Fan
  (2 fans)

1) Do not cut health financing, rather boost it,

2) Drop the debt,

3) Make medicines accessible and available to all because we cannot accept an apartheid when it comes to access to medicines - human lives of those in Global South are not regarded as having the same value as those in the Global North,

4) Support communities as they know best, and

5) Reject hate and choose love."

Affordable and accessible health choices for everyone

Study results in June 2024 showed that a new long-acting medicine called Lenacapavir helps protect young girls and women from HIV 100% (when used as a Pre-Exposure Prophylaxis or PrEP - and taken twice yearly - one injection every six months). But the price of this medicine is over US$ 40,000 per person per year.

However, generic manufacturers may be able to make Lenacapavir for less than US$ 100 per person per year, shares Winnie. "GILEAD and other patent holders of long-acting treatments and PrEP HIV prevention tools need to grant generic licensing using the UN-backed Medicine Patents Pool and make those generics available for all people in Africa, Asia Pacific, and Latin America," said Winnie.

"Many technical innovations are only transformative if they are available for those who need them," she added.

We can make AIDS a history: But will we do so?

Next Page  1  |  2  |  3  |  4  |  5  |  6  |  7

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Rate It | View Ratings

Citizen News Service - CNS Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Citizen News Service (CNS) specializes in in-depth and rights-based, health and science journalism. For more information, please contact: www.citizen-news.org or @cns_health or www.facebook.com/cns.page
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter

Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

The chasm between TB and HIV continues

Management of respiratory diseases beyond drugs: Pulmonary Rehabilitation

Oxygen therapy is like a prescription drug: Use it rationally

New funding boosts research for controlling TB, malaria, dengue and leishmaniasis

Why are shorter, safer and more effective treatments for drug-resistant TB not being rolled out?

Another feather in the cap of treatment as HIV prevention

To View Comments or Join the Conversation:

Tell A Friend